Investing in Cancer Research

Australia

Lung cancer will affect

12,434 families

in Australia this year.

Dr Jill Larsen Can Too Lung Cancer Researcher

Can Too has invested in

4 researchers

working on lung cancer.

Can Too Cancer Research Lung Cancer

Lung cancer patients have

16% survival rate

thanks to cancer research.

What is Lung Cancer?

Lung cancer occurs when abnormal cells in the lung grow in an uncontrolled way. According to Cancer Australia, it often spreads (metastasises) to other parts of the body before the cancer can be detected in the lungs.

With a poor percentage of survival during the first 5 years – at 16% - inspiring researchers such as Dr Jill Larsen, a Research Officer at the QIMR Berghofer Medical Research Institute who received a grant supported by Can Too in 2015, has spent over 14 years researching the genes that drive lung cancer. Dr Larsen considers lung cancer to be one of the “underdogs” of the disease, despite it being the most common cause of cancer death in men and women worldwide.

Can Too Foundation has invested in 4 lung cancer research projects since 2005.

“My ultimate goal is to improve the outcomes of patients with lung cancer.”

Dr Jill Larsen, Lung Cancer Researcher

Our Investment in Lung Cancer Research

Sign up to our newsletter